We are de-risking biomedical innovation, turning biomedical knowledge into social and economic value.
More than three decades later, we remain committed in pursuit of pharmaceutical innovation, providing high quality products and striving to deliver superior business results.
The patient is at the heart of what we do, making decisions regarding biometric innovation is usually a complicated and chaotic procedure as it consists of various product options, various facets to ascertain these on, and multiple evaluations at all levels.
Discover our therapeutic areas, where we continuously invest to innovate and deliver therapeutic solutions for patient’s benefit.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
17
Sep 2026
Researchers found that mice later classified as resilient showed stronger coordination between neuronal OFF-periods and slow-wave activity in the prelimbic cortex even before social stress. After social defeat, resilient mice also showed a distinct reorganization of neuronal silence during NREM sleep, linking local sleep dynamics with behavioral resilience.
17
Sep 2026
Medical assistance can help women suffering from severe nausea and vomiting during pregnancy, but insufficient recognition of Hyperemesis gravidarum (HG) means that many are not getting the help they need to overcome this severe and debilitating form of morning sickness.
17
Sep 2026
Siemens Healthineers announced today that the automated hemostasis analyzers for mid- and high-volume laboratories are now available for patient testing in the United States.
17
Sep 2026
Researchers from the Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the Keck School of Medicine of USC have developed a new, noninvasive way to examine how blood flow and cellular organization align across the layers of the living human brain.